Your session is about to expire
← Back to Search
Local Anesthetic
ESPB Solutions for Breast Cancer
Phase 2
Waitlist Available
Research Sponsored by Tufts Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare pain scores of two different methods of pain management for subjects undergoing bilateral surgical intervention for breast cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Pain Score at 48 hours
Secondary study objectives
Pain Scores at 6, 12, 18, 24, 30, 38, 42, and 72 hours
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Control arm will receive standard of care solution for the ESPB block
Group II: Liposomal BupivicaineActive Control1 Intervention
Liposomal Bupivicaine arm will receive Liposomal Bupivicaine for the ESPB block
Find a Location
Who is running the clinical trial?
Tufts Medical CenterLead Sponsor
263 Previous Clinical Trials
264,386 Total Patients Enrolled
3 Trials studying Breast Cancer
51 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are pregnant.Newborns who may not survive.You are allergic or have a bad reaction to the study medication.Babies who are born without signs of life.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Liposomal Bupivicaine
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger